I really don't want to be a doctor

Chapter 457 Recruiting Test Patients

This, what happened?
Jing Xiaoran looked back at Li Jiajia, and found that she smiled at him.

"Jing, Brother Jing..."

At this time, Li Feng hurried to Jing Xiaoran.

"I hope to have a happy cooperation with Shenzhou Laboratory in the future, and the third phase of clinical trials will be covered by me."

Hearing this, Jing Xiaoran knew the whole story. It turned out that Li Jiajia handed over all the cooperation matters to Li Feng for overall management.

"Happy cooperation." Jing Xiaoran nodded.

After all, Li Feng is a rich second generation who came out to be gilded, and the property of the Li Group will definitely be handed over to Li Jiajia and Li Feng in the future.

If there is no special performance, it will be difficult to convince the public.

Jing Xiaoran's impression of Li Feng is relatively small, and he still stays in the typical playboy of the rich second generation when they met in Kyoto.

……

Next, Mr. Li and his team stayed in the laboratory for a while, visited the immune checkpoint inhibitor project, and then went inside.

"Xiao Ran, grandpa and I will stay in Fancheng for a while, and when you finish your work, I will treat you to dinner."

Before Li Jiajia left, she made an appointment with Jing Xiaoran for a meal.

After Mr. Li and his party left, Lin Yitian thought about his next plan, and couldn't believe it.

"Xiao Ran, did we succeed in such a simple cooperation?"

Li's Pharmaceutical Factory is one of the most famous pharmaceutical companies in China, so it is so simple to cooperate with Shenzhou Laboratory?
According to Jing Xiaoran's plan for the future, the establishment of a pharmaceutical company is certain, so Li's Pharmaceutical Factory is helping competitors!

"I think, during Xiao Ran's trip to the capital this time, something must have happened that we don't know about." Zhu Xianqing said with a smile.

From Mr. Li's attitude towards Jing Xiaoran, everyone can see that the relationship between the two may be unusual.

Seeing that everyone was very interested, Jing Xiaoran told everyone what happened on the plane.

"Hey, Xiao Ran, I remember that although you are a clinical medical student, your internship is not over yet." Yitian Lin wondered, "How did you judge Mr. Li's condition at that time? And how could you do it under such critical conditions?" To pneumothorax puncture?"

All eyes on the scene turned to Jing Xiaoran.

Everyone is very surprised, it's okay for Jing Xiaoran to be good at scientific research, how can he be so good at curing diseases and saving lives?
Jing Xiaoran smiled, and tried to fool him, "I saw this sudden pneumothorax once in the clinic. The teacher once guided me. It should be considered luck, so the puncture was successful."

Although Jing Xiaoran's words are a bit far-fetched, everyone can only believe it for the time being.

"Hey, people are really more popular than people!"

"That's right! I haven't even gotten into scientific research yet, and everyone else has started both scientific research and clinical practice!"

"Xiao Ran, if you don't have a girlfriend, I must introduce my daughter to you."

……

Everyone was chattering, and the laboratory was very lively for a while.

Although the meeting with Lee's Pharmaceuticals was relatively short this time, it solved a huge problem in the immune checkpoint inhibitor project.

After the handover between Li's Pharmaceuticals and Shenzhou Laboratories is completed, the Phase III clinical trials of immune checkpoint inhibitors can officially begin!

……

Time flies, and in the next half month, Shenzhou Laboratory suddenly became idle. Of course, this is only for the immune checkpoint inhibitor project team.

Because the basic research has ended, everyone is currently preparing for clinical trials.

Li Feng is a good guy, he knows the importance of Jing Xiaoran to his mission, so he will come to the Shenzhou Laboratory every two days to show his presence in front of Jing Xiaoran.

"Brother Jing, I heard that you are going to the Central Hospital to start the first batch of clinical trials at noon tomorrow?" Li Feng said.

Jing Xiaoran said: "Well, I have asked the Fancheng Health Committee to contact the Fancheng Cancer Hospital, we can go there anytime."

"Then how many patients have you recruited to participate in clinical trials?" Li Feng continued.

The basis of clinical trials is to recruit patients for experiments and sign informed consent.

The domestic scientific research environment is relatively severe, and patients rarely actively participate in clinical trials.

They don't want to be regarded as guinea pigs for research, unless they are patients with advanced tumors and multiple metastases. At this time, they can only participate in some clinical trials.

This time, Shenzhou Lab's immune checkpoint inhibitor project is no exception!
There is little information on this aspect in China. Except for a few cutting-edge tumor laboratories who have knowledge of immune checkpoint inhibitors, ordinary doctors have never heard of immune checkpoint inhibitors, let alone ordinary people.

Therefore, the biggest problem facing Shenzhou Laboratories is to recruit enough patients for experiments.

That's why Jing Xiaoran needs to rely on the clinical trial teams of Li's Pharmaceutical Factory in major hospitals in Fancheng to recruit test patients, and then conduct phase III clinical trials of immune checkpoint inhibitors.

"Brother Li, to be honest, there are only two patients who are sure to participate in clinical trials." Jing Xiaoran said.

"Only two?" Li Feng frowned. Although he didn't know much about scientific research, he was familiar with the medical circle and knew that the number of patients involved in these three phases of clinical trials was extremely large.

The clinical laboratory is divided into four phases, and the number of people in each phase has strict requirements.

The third phase of clinical trials is the stage of confirming the therapeutic effect.Its purpose is to further verify the therapeutic effect and safety of the drug on patients with target indications, evaluate the relationship between benefits and risks, and finally provide a sufficient basis for the approval of drug registration applications.The number of patients required to participate in the trial is 1000-3000.

After the third phase of clinical trials, it is the fourth phase of clinical trials.

Phase IV clinical trial is the application research stage independently conducted by the applicant after the new drug is marketed.Its purpose is to investigate the curative effect and adverse reactions of drugs under the conditions of widespread use; to evaluate the relationship between benefits and risks used in general or special populations; to improve the dosage, etc.The number of patients required to participate in the trial is generally more than 2000.

There are only two people in Shenzhou Lab now?
This is too far away!

"Brother Jing, haven't you promoted immune checkpoint inhibitors in major hospitals before?" Li Feng asked suspiciously.

Generally speaking, before large pharmaceutical companies conduct phase III clinical trials, they will publicize in advance in the departments of major hospitals and communicate with the heads of the departments.

In this way, when a qualified test patient is encountered, the doctor in charge of the bed will directly recruit the patient for clinical trials.

Jing Xiaoran shook his head, "The Phase II clinical trial has just ended, and now the Phase III clinical trial is going on non-stop, how can there be time to publicize it?"

"Then...then you have a lot of work to do!" Li Feng sighed involuntarily.

It seems that the job arranged by my elder sister is really not easy!

(End of this chapter)